Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$653M |
| 2 |
Amazon
AMZN
|
+$602M |
| 3 |
ExxonMobil
XOM
|
+$473M |
| 4 |
Tesla
TSLA
|
+$437M |
| 5 |
Starbucks
SBUX
|
+$380M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$511M |
| 2 |
Netflix
NFLX
|
+$427M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$397M |
| 4 |
Nike
NKE
|
+$373M |
| 5 |
Microsoft
MSFT
|
+$365M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.68% |
| 2 | Healthcare | 17.69% |
| 3 | Consumer Discretionary | 13.09% |
| 4 | Industrials | 7.96% |
| 5 | Consumer Staples | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SY
2526
So-Young International
SY
$212M
| $829K | ﹤0.01% |
642,328
-23,996
| -4% | -$26.5K |
|
|
ODP
2527
DELISTED
ODP
ODP
| $822K | ﹤0.01% |
14,600
-101,592
| -87% | -$4.83M |
|
|
CODX
2528
Co-Diagnostics
CODX
$5.53M
| $821K | ﹤0.01% |
20,567
-646
| -3% | -$22.8K |
|
2529
QuinStreet
QNST
$1.18B
| $820K | ﹤0.01% |
64,000
-104,500
| -62% | -$1.18M |
|
|
ARIS
2530
DELISTED
Aris Water Solutions
ARIS
| $819K | ﹤0.01% |
97,633
+41,633
| +74% | +$358K |
|
2531
Electromed
ELMD
$345M
| $819K | ﹤0.01% |
75,052
+17,148
| +30% | +$179K |
|
2532
Planet Fitness
PLNT
$3.98B
| $818K | ﹤0.01% |
11,200
-54,700
| -83% | -$3.36M |
|
|
ASM
2533
Avino Silver & Gold Mines
ASM
$1.18B
| $817K | ﹤0.01% |
1,558,400
+394,000
| +34% | +$193K |
|
2534
State Street SPDR MSCI ACWI ex-US ETF
CWI
$2.85B
| $817K | ﹤0.01% |
30,200
+7,900
| +35% | +$201K |
|
|
UBFO
2535
DELISTED
United Security Bancshares
UBFO
| $814K | ﹤0.01% |
96,848
+35,053
| +57% | +$274K |
|
2536
State Street SPDR S&P Aerospace & Defense ETF
XAR
$6.37B
| $813K | ﹤0.01% |
6,000
+4,000
| +200% | +$493K |
|
2537
Vanguard S&P 500 Growth ETF
VOOG
$27.1B
| $812K | ﹤0.01% |
18,000
-3,600
| -17% | -$154K |
|
2538
B&G Foods
BGS
$281M
| $811K | ﹤0.01% |
77,200
+10,700
| +16% | +$99K |
|
2539
Avantis US Large Cap Value ETF
AVLV
$18.1B
| $809K | ﹤0.01% |
+14,000
| New | +$753K |
|
2540
Ponce Financial Group
PDLB
$482M
| $809K | ﹤0.01% |
82,894
-3,900
| -4% | -$33.7K |
|
|
SELF
2541
Global Self Storage
SELF
$58.7M
| $809K | ﹤0.01% |
174,588
+66,533
| +62% | +$309K |
|
2542
ThredUp
TDUP
$424M
| $808K | ﹤0.01% |
359,112
+45,400
| +14% | +$118K |
|
2543
Spero Therapeutics
SPRO
$72.4M
| $805K | ﹤0.01% |
547,465
+300
| +0.1% | +$358 |
|
|
WHWK
2544
Whitehawk Therapeutics
WHWK
$237M
| $805K | ﹤0.01% |
398,722
+152,800
| +62% | +$641K |
|
2545
Avantis International Small Cap Value ETF
AVDV
$19.8B
| $800K | ﹤0.01% |
12,796
+4,596
| +56% | +$268K |
|
2546
First Trust Health Care AlphaDEX Fund
FXH
$1.08B
| $797K | ﹤0.01% |
7,700
+2,800
| +57% | +$270K |
|
|
NOAH
2547
Noah Holdings
NOAH
$599M
| $791K | ﹤0.01% |
57,300
-24,500
| -30% | -$310K |
|
2548
Oramed Pharmaceuticals
ORMP
$181M
| $788K | ﹤0.01% |
341,073
+296,773
| +670% | +$634K |
|
2549
Sinclair Inc
SBGI
$1.08B
| $787K | ﹤0.01% |
+60,435
| New | +$742K |
|
|
PMD
2550
DELISTED
Psychemedics Corporation
PMD
| $786K | ﹤0.01% |
265,563
-8,100
| -3% | -$21.6K |
|
Similar funds
Renaissance Technologies's Q4 2023 Portfolio in Review
As of Q4 2023, Renaissance Technologies held 4,318 positions worth $64.6B, up 10% from $58.7B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Renaissance Technologies's Q4 2023 filing shows 702 new, 1,590 increased, 1,355 reduced and 633 closed positions. Its largest new stake was Amazon: 4,296,466 shares worth $653M. The largest sale was Berkshire Hathaway Class A, an estimated $511M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 19% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Renaissance Technologies's largest Q4 2023 buy was Amazon: 4,296,466 shares worth $653M.
- Renaissance Technologies added most to Meta Platforms (Facebook) in Q4 2023, an estimated $653M increase.
- Renaissance Technologies's biggest Q4 2023 reduction was Berkshire Hathaway Class A, cutting an estimated $511M.
- Renaissance Technologies fully exited Horizon Therapeutics Public Limited Company Ordinary Shares in Q4 2023, selling an estimated $397M.
- Renaissance Technologies's ten largest holdings make up 12% of its $64.6B portfolio in Q4 2023.
- Renaissance Technologies opened 702 new positions and closed 633 in Q4 2023.
- Renaissance Technologies's portfolio value rose 10% quarter-over-quarter to $64.6B.
Based on Renaissance Technologies's 13F filing for Q4 2023, filed 13 Feb 2024.